Lymphangiomyoma

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 69 Experts worldwide ranked by ideXlab platform

Soo Jin Jung - One of the best experts on this subject based on the ideXlab platform.

  • Chylopericardium Secondary to Lymphangiomyoma - A case report -.
    The Korean Journal of Thoracic and Cardiovascular Surgery, 2011
    Co-Authors: Seongmin Ko, Kyung-taek Park, Young Chul Yoon, Soo Jin Jung
    Abstract:

    Chylopericardium is a rare disease entity characterized by the accumulation of chylous fluid in the pericardial sac. It usually arises from mediastinal neoplasms, thrombosis of the subclavian vein, tuberculosis, nonsurgical trauma, thoracic or cardiac surgery. The spectrum of symptoms for chylopericardium varies from an incidental finding of cardiomegaly to dyspnea, upper abdominal discomfort, cough, chest pain, palpitation, fatigue. However, most of the patients are asymptomatic. The main purpose of treatment of chylopericardium is the prevention of cardiac tamponade and prevention of metabolic, nutritional, and immunological compromise due to chyle leak. Here, we report a case of chylopercardium secondary to Lymphangiomyoma with review of the literature.

Seongmin Ko - One of the best experts on this subject based on the ideXlab platform.

  • Chylopericardium Secondary to Lymphangiomyoma - A case report -.
    The Korean Journal of Thoracic and Cardiovascular Surgery, 2011
    Co-Authors: Seongmin Ko, Kyung-taek Park, Young Chul Yoon, Soo Jin Jung
    Abstract:

    Chylopericardium is a rare disease entity characterized by the accumulation of chylous fluid in the pericardial sac. It usually arises from mediastinal neoplasms, thrombosis of the subclavian vein, tuberculosis, nonsurgical trauma, thoracic or cardiac surgery. The spectrum of symptoms for chylopericardium varies from an incidental finding of cardiomegaly to dyspnea, upper abdominal discomfort, cough, chest pain, palpitation, fatigue. However, most of the patients are asymptomatic. The main purpose of treatment of chylopericardium is the prevention of cardiac tamponade and prevention of metabolic, nutritional, and immunological compromise due to chyle leak. Here, we report a case of chylopercardium secondary to Lymphangiomyoma with review of the literature.

Young Chul Yoon - One of the best experts on this subject based on the ideXlab platform.

  • Chylopericardium Secondary to Lymphangiomyoma - A case report -.
    The Korean Journal of Thoracic and Cardiovascular Surgery, 2011
    Co-Authors: Seongmin Ko, Kyung-taek Park, Young Chul Yoon, Soo Jin Jung
    Abstract:

    Chylopericardium is a rare disease entity characterized by the accumulation of chylous fluid in the pericardial sac. It usually arises from mediastinal neoplasms, thrombosis of the subclavian vein, tuberculosis, nonsurgical trauma, thoracic or cardiac surgery. The spectrum of symptoms for chylopericardium varies from an incidental finding of cardiomegaly to dyspnea, upper abdominal discomfort, cough, chest pain, palpitation, fatigue. However, most of the patients are asymptomatic. The main purpose of treatment of chylopericardium is the prevention of cardiac tamponade and prevention of metabolic, nutritional, and immunological compromise due to chyle leak. Here, we report a case of chylopercardium secondary to Lymphangiomyoma with review of the literature.

Kyung-taek Park - One of the best experts on this subject based on the ideXlab platform.

  • Chylopericardium Secondary to Lymphangiomyoma - A case report -.
    The Korean Journal of Thoracic and Cardiovascular Surgery, 2011
    Co-Authors: Seongmin Ko, Kyung-taek Park, Young Chul Yoon, Soo Jin Jung
    Abstract:

    Chylopericardium is a rare disease entity characterized by the accumulation of chylous fluid in the pericardial sac. It usually arises from mediastinal neoplasms, thrombosis of the subclavian vein, tuberculosis, nonsurgical trauma, thoracic or cardiac surgery. The spectrum of symptoms for chylopericardium varies from an incidental finding of cardiomegaly to dyspnea, upper abdominal discomfort, cough, chest pain, palpitation, fatigue. However, most of the patients are asymptomatic. The main purpose of treatment of chylopericardium is the prevention of cardiac tamponade and prevention of metabolic, nutritional, and immunological compromise due to chyle leak. Here, we report a case of chylopercardium secondary to Lymphangiomyoma with review of the literature.

Francis X Mccormack - One of the best experts on this subject based on the ideXlab platform.

  • lymphangioleiomyomatosis new concepts in pathogenesis diagnosis and treatment
    Seminars in Respiratory and Critical Care Medicine, 2012
    Co-Authors: Riffat Meraj, Kathryn A Wikenheiserbrokamp, Lisa R Young, Francis X Mccormack
    Abstract:

    Lymphangioleiomyomatosis (LAM) is a slowly progressive lung disease that is associated with mutations in tuberous sclerosis complex genes, infiltration of the pulmonary parenchyma and lymphatics with neoplastic smooth muscle cells, extensive tissue remodeling and architectural distortion of the lung, and tumors of the chest and abdomen, including Lymphangiomyomas and angiomyolipomas. LAM occurs in women in the general population and in patients of both genders with tuberous sclerosis. Overt clinical manifestations of LAM occur almost exclusively in females, however, and include progressive dyspnea on exertion, recurrent pneumothorax, and chylous effusions. The molecular basis of LAM has been extensively characterized over the past decade, resulting in the development of a targeted therapy. This article reviews emerging approaches to the diagnosis and treatment of LAM.